Publications
See a complete PubMed list of publications by Xiaojiang Cui, PhD.
Selected Key Publications
- Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19(10):858-868. https://www.tandfonline.com/doi/full/10.1080/15384047.2018.1456599.
- Sims JD, Taguiam JM, Alonso-Valenteen F, Markman J, Agadjanian H, Chu D, Lubow J, Abrol R, Srinivas D, Jain A, Han B, Qu Y, Mirzadehgan P, Hwang JY, Rentsendorj A, Chung A, Lester J, Karlan BY, Gray HB, Gross Z, Giuliano A, Cui X, Medina-Kauwe LK. Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics. J Control Release. 2018 Feb 10;271:127-138. https://www.sciencedirect.com/science/article/pii/S0168365917310945.
- Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, Tanaka H, Yang W, Giuliano AE, Cui X. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2018 Mar;37(10):1399-1408. https://www.nature.com/articles/s41388-017-0021-2.
- Gao B, Qu Y, Han B, Nagaoka Y, Katsumata M, Deng N, Bose S, Jin L, Giuliano AE, Cui X. Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland. Sci Rep. 2017 Oct 25;7(1):14017. https://www.nature.com/articles/s41598-017-14342-8.
- Han B, Bhowmick N, Qu Y, Chung S, Giuliano AE, Cui X. FOXC1: an emerging marker and therapeutic target for cancer. Oncogene. 2017 Jul 13;36(28):3957-3963. https://www.nature.com/articles/onc201748.
- Qu Y, Han B, Gao B, Bose S, Gong Y, Wawrowsky K, Giuliano AE, Sareen D, Cui X. Differentiation of human induced pluripotent stem cells to mammary-like organoids. Stem Cell Reports. 2017 Feb 14;8(2):205-215. https://www.sciencedirect.com/science/article/pii/S2213671116303137.
- Qu Y, Zhou B, Yang W, Han B, Yu-Rice Y, Gao B, Johnson J, Svendsen CN, Freeman MR, Giuliano AE, Sareen D, Cui X. Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs. Sci Rep. 2016 Aug 23;6:32007. https://www.nature.com/articles/srep32007.
- Yu-Rice Y, Jin Y, Han B, Qu Y, Johnson J, Watanabe T, Cheng L, Deng N, Tanaka H, Gao B, Liu Z, Sun Z, Bose S, Giuliano AE, Cui X. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance. Oncogene. 2016 Oct 13;35(41):5400-5411. https://www.nature.com/articles/onc201678.
- Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, Sakkiah S, Abrol R, Jensen TW, Berman BP, Tanaka H, Johnson J, Gao B, Hao J, Liu Z, Buttyan R, Ray PS, Hung MC, Giuliano AE, Cui X. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Cell Rep. 2015 Nov 3;13(5):1046-1058. https://www.sciencedirect.com/science/article/pii/S2211124715011055.
- Yue Y, Cui X, Bose S, Audeh W, Zhang X, Fraass B. Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging. Breast Cancer Res Treat. 2015 Oct;153(3):607-616. https://link.springer.com/article/10.1007/s10549-015-3558-1.
- Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, et al. Diagnosis of basal-like breast cancer using a FOXC1-based assay. J Natl Cancer Inst. 2015 Jun 3;107(8). https://academic.oup.com/jnci/article/107/8/djv148/948868.
- Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene. 2012;31(45):4798-4802. http://www.nature.com/onc/journal/v31/n45/full/onc2011635a.html.
- Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, Huang P, Martens JW, Giuliano AE, Zhang N, Cheng NH, Cui X. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. J Clin Invest. 2011;121(1):212-225. http://www.jci.org/articles/view/43144.
- Ray PS, Wang J, Qu Y, Shin-Sim M, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DSB, Giuliano AE, Cui X. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010;70(10):3870-3876. https://aacrjournals.org/cancerres/article/70/10/3870/559488/FOXC1-Is-a-Potential-Prognostic-Biomarker-with.
- Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Mills GB. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009;15(6):539-550. http://www.cell.com/cancer-cell/abstract/S1535-6108(09)00115-9.
Contact the Cui Lab
8700 Beverly Blvd.
Davis Building, Rooms 2055 and 2056
Los Angeles, CA 90048